RU98120519A - AUTOANTIGEN AND STRUCTURAL-RELATED PROTEINS FOR USE IN IMMUNOTHERAPY OF AUTOIMMUNE DISEASES - Google Patents
AUTOANTIGEN AND STRUCTURAL-RELATED PROTEINS FOR USE IN IMMUNOTHERAPY OF AUTOIMMUNE DISEASESInfo
- Publication number
- RU98120519A RU98120519A RU98120519/14A RU98120519A RU98120519A RU 98120519 A RU98120519 A RU 98120519A RU 98120519/14 A RU98120519/14 A RU 98120519/14A RU 98120519 A RU98120519 A RU 98120519A RU 98120519 A RU98120519 A RU 98120519A
- Authority
- RU
- Russia
- Prior art keywords
- protein
- amino acid
- acid sequence
- homology
- exhibits
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title claims 15
- 108090000623 proteins and genes Proteins 0.000 title claims 15
- 206010003816 Autoimmune disease Diseases 0.000 title 1
- 238000009169 immunotherapy Methods 0.000 title 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 10
- 241000283690 Bos taurus Species 0.000 claims 4
- 101000173656 CHI3L2 Proteins 0.000 claims 4
- 210000002966 Serum Anatomy 0.000 claims 4
- 102000036108 human CHI3L2 protein Human genes 0.000 claims 4
- 241001465754 Metazoa Species 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 229920003013 deoxyribonucleic acid Polymers 0.000 claims 2
- 230000001939 inductive effect Effects 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 206010003246 Arthritis Diseases 0.000 claims 1
- 210000000845 Cartilage Anatomy 0.000 claims 1
- 239000000427 antigen Substances 0.000 claims 1
- 102000038129 antigens Human genes 0.000 claims 1
- 108091007172 antigens Proteins 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
Claims (11)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/634,493 | 1996-04-18 | ||
US08/634.493 | 1996-04-18 | ||
US08/634,493 US5843449A (en) | 1996-03-25 | 1996-04-18 | Proteins and novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
RU98120519A true RU98120519A (en) | 2000-09-20 |
RU2189248C2 RU2189248C2 (en) | 2002-09-20 |
Family
ID=24544023
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU98120519/14A RU2189248C2 (en) | 1996-04-18 | 1997-04-15 | Autoantigen and structurally related proteins for using in immunotherapy of autoimmune diseases |
Country Status (16)
Country | Link |
---|---|
US (1) | US5843449A (en) |
EP (1) | EP0904369A1 (en) |
JP (1) | JP2000509265A (en) |
KR (1) | KR20000005476A (en) |
CN (1) | CN1216582A (en) |
AU (1) | AU724547B2 (en) |
BR (1) | BR9708714A (en) |
CA (1) | CA2251584A1 (en) |
CZ (1) | CZ333398A3 (en) |
HU (1) | HU221348B1 (en) |
NO (1) | NO984835L (en) |
NZ (1) | NZ332311A (en) |
PL (1) | PL187451B1 (en) |
RU (1) | RU2189248C2 (en) |
TR (1) | TR199802082T2 (en) |
WO (1) | WO1997040149A1 (en) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5928928A (en) * | 1995-06-07 | 1999-07-27 | Universiteit Van Amsterdam | Human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
WO2000004917A2 (en) * | 1998-07-23 | 2000-02-03 | Akzo Nobel N.V. | USE OF HC gp-39 IN IMMUNE DISEASES |
US20050197283A1 (en) * | 1998-10-04 | 2005-09-08 | Vascular Biogenics Ltd. | Compositions containing beta 2-glycoprotein I for the prevention and/or treatment of vascular disease |
IL126447A (en) * | 1998-10-04 | 2004-09-27 | Vascular Biogenics Ltd | Immunological and oral tolerance-inducing composition and use thereof for the prevention and/or for the treatment of atherosclerosis |
US20020102581A1 (en) * | 1999-02-19 | 2002-08-01 | Hageman Gregory S. | Diagnostics and therapeutics for ocular disorders |
US7534605B2 (en) * | 1999-06-08 | 2009-05-19 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases |
US7011952B2 (en) * | 2000-02-22 | 2006-03-14 | University Of Iowa Research Foundation | Diagnostics and therapeutics for macular degeneration-related disorders |
AU6110301A (en) * | 2000-04-29 | 2001-11-12 | Univ Iowa Res Found | Diagnostics and therapeutics for macular degeneration-related disorders |
CN1352087A (en) * | 2000-11-02 | 2002-06-05 | 上海博德基因开发有限公司 | New polypeptide-human glycoprotein 42 and polynucleotide for encoding such polypeptide |
GB0105360D0 (en) * | 2001-03-03 | 2001-04-18 | Glaxo Group Ltd | Chimaeric immunogens |
US7265208B2 (en) * | 2001-05-01 | 2007-09-04 | The Regents Of The University Of California | Fusion molecules and treatment of IgE-mediated allergic diseases |
US8195187B2 (en) | 2001-06-25 | 2012-06-05 | Airvana Network Solutions, Inc. | Radio network control |
US8160020B2 (en) | 2001-06-25 | 2012-04-17 | Airvana Network Solutions, Inc. | Radio network control |
CA2454342A1 (en) * | 2001-07-24 | 2003-02-06 | Yale University | Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
WO2005081980A2 (en) * | 2004-02-25 | 2005-09-09 | Medimmune, Inc. | Methods and compositions relating to chitinases and chitinase-like molecules and modulation of osteoclasts |
US8099504B2 (en) | 2005-06-24 | 2012-01-17 | Airvana Network Solutions, Inc. | Preserving sessions in a wireless network |
EP1928496A4 (en) * | 2005-08-31 | 2011-01-05 | Medimmune Inc | C/clp antagonists and methods of use thereof |
US7751835B2 (en) | 2005-10-04 | 2010-07-06 | Airvana, Inc. | Non-circular paging areas |
US8145221B2 (en) | 2005-12-16 | 2012-03-27 | Airvana Network Solutions, Inc. | Radio network communication |
US8094630B2 (en) | 2005-12-16 | 2012-01-10 | Airvana Network Solutions, Inc. | Radio frequency dragging prevention |
US8619702B2 (en) | 2005-12-16 | 2013-12-31 | Ericsson Evdo Inc. | Radio network control |
US8085696B2 (en) | 2006-07-14 | 2011-12-27 | Airvana Networks Solutions, Inc. | Dynamic modification of route update protocols |
US8843638B2 (en) | 2007-12-13 | 2014-09-23 | Ericsson Evdo Inc. | Handing off active connections |
AR072897A1 (en) | 2008-08-05 | 2010-09-29 | Novartis Ag | COMPOSITIONS AND METHODS FOR ANTIBODIES GOING TO COMPLEMENT PROTEIN C5 |
US20170073754A1 (en) | 2014-02-07 | 2017-03-16 | Novartis Ag | Impact of genetic factors on disease progression and response to anti-c5 antibody in geographic atrophy |
CA2951984C (en) | 2014-07-15 | 2023-10-03 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Isolated polypeptides of cd44 and uses thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4284623A (en) * | 1979-11-09 | 1981-08-18 | Beck Lee R | Method of treating inflammation using bovine milk |
JPS6323898A (en) * | 1986-07-16 | 1988-02-01 | Dainippon Pharmaceut Co Ltd | Novel polypeptide, dna coding said polypeptide and production thereof |
CA2164498C (en) * | 1993-07-09 | 2007-09-11 | Paul A. Price | Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices |
BR9507452A (en) * | 1994-04-08 | 1997-08-05 | Brigham & Womens Hospital | Pharmaceutical composition use of a non-interferon polypeptide use of a quantity of a standardized antigen and a quantity of a non-interferon polypeptide and product containing (1) a quantity of a standardized antigen and (11) a quantity of a non-interferon polypeptide |
IL115744A (en) * | 1994-10-27 | 2000-07-16 | Akzo Nobel Nv | Peptides comprising a subsequence of human cartilage glycoprotein - 39 |
-
1996
- 1996-04-18 US US08/634,493 patent/US5843449A/en not_active Expired - Fee Related
-
1997
- 1997-04-15 JP JP9537477A patent/JP2000509265A/en not_active Ceased
- 1997-04-15 WO PCT/EP1997/001903 patent/WO1997040149A1/en not_active Application Discontinuation
- 1997-04-15 EP EP97919370A patent/EP0904369A1/en not_active Withdrawn
- 1997-04-15 NZ NZ332311A patent/NZ332311A/en unknown
- 1997-04-15 BR BR9708714A patent/BR9708714A/en not_active Application Discontinuation
- 1997-04-15 RU RU98120519/14A patent/RU2189248C2/en not_active IP Right Cessation
- 1997-04-15 CN CN97193881A patent/CN1216582A/en active Pending
- 1997-04-15 KR KR1019980708253A patent/KR20000005476A/en not_active Application Discontinuation
- 1997-04-15 CA CA002251584A patent/CA2251584A1/en not_active Abandoned
- 1997-04-15 HU HU9903378A patent/HU221348B1/en not_active IP Right Cessation
- 1997-04-15 AU AU23869/97A patent/AU724547B2/en not_active Ceased
- 1997-04-15 TR TR1998/02082T patent/TR199802082T2/en unknown
- 1997-04-15 CZ CZ983333A patent/CZ333398A3/en unknown
- 1997-04-15 PL PL97329350A patent/PL187451B1/en not_active IP Right Cessation
-
1998
- 1998-10-16 NO NO984835A patent/NO984835L/en not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU98120519A (en) | AUTOANTIGEN AND STRUCTURAL-RELATED PROTEINS FOR USE IN IMMUNOTHERAPY OF AUTOIMMUNE DISEASES | |
Julliard et al. | High-molecular-weight immunoreactive β-endorphin in extracts of human placenta is a fragment of immunoglobulin G | |
EP2848627A3 (en) | Treatment of autoimmune conditions with copolymer 1 and related copolymers and peptides | |
NZ332311A (en) | Use of autoantigen HC gp-39 and proteins structurally related thereto in immunotherapy of autoimmune diseases particularly rheumatoid arthritis | |
RU2000131593A (en) | SELECTIVE AGONISTS AND ANTAGONISTS IL-2. | |
RU2000124084A (en) | Chimeric antibody that binds to human CD40 (variants), nucleic acid molecule (variants), expression vector (variants), humanized antibody (variants), pharmaceutical composition for treating a T-cell mediated disease (variants), method for treating a patient for a disease mediated by T cells (options) | |
AR018603A1 (en) | A PEPTIDE, USEFUL FOR THE TREATMENT AND / OR PROFILAXIS OF ALZHEIMER'S DISEASE AND THE DOWN SYNDROME, PHARMACEUTICAL COMPOSITIONS AND VACCINES WHICH LOCATE, THE USE OF SUCH PEPTIDE FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS OF DNA, SECTION A PLASMID OR VECTOR VI | |
JP2003528827A5 (en) | ||
RU2010120571A (en) | THYMUS SPECIFIC PROTEIN | |
EP2371847A1 (en) | Peptides and their derived type APL of the HSP60 and pharmaceutical compositions | |
RU97105374A (en) | MODIFIED PROTEINS | |
PT84089A (en) | Dna sequences coding for proteins having the biological activity of husi-type i inhibitors biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins | |
JPH05506247A (en) | Antagonist of human gamma interferon | |
US20070264229A1 (en) | Peptides for Treatment of Autoimmune Disease | |
EA027229B1 (en) | Peptide which is a fragment of factor viii, and composition for suppressing or preventing the production of factor viii inhibitor antibodies in vivo | |
ATE310828T1 (en) | IMPLANT AND VECTOR FOR THE TREATMENT OF ACQUIRED DISEASES | |
HUP0102975A2 (en) | Chemotaxis-inhibiting protein of staphylococcus (chips) and its use | |
DE69837265D1 (en) | POLYPEPTIDES FOR REGENERATING THE NERVOUS SYSTEM | |
IE863281L (en) | Human placenta angiogenic factor capable of stimulating¹capillary endothelial cell protease synthesis, DNA synthesis¹and migration. | |
MXPA01011158A (en) | Growth factor homolog zvegf4. | |
Low et al. | Thymosins: Isolation, structural studies, and biological activities | |
HUP0001057A2 (en) | Bovine lactation associated immunotropic protein (cd14), encoding gene and application in b cell activation | |
DE69330348D1 (en) | Use of peptides which cause an immune response in the manufacture of medicaments for inducing immunosuppression. | |
RU2001105086A (en) | NEW PEPTIDES FOR APPLICATION IN IMMUNOTHERAPY OF AUTOIMMUNE DISEASES | |
CA2163805A1 (en) | Novel activating factor of leukocytes |